Explore the latest developments concerning Live Oak Private.
Live Oak Private Wealth LLC Has $449,000 Stake in Pfizer Inc. $PFE
Live Oak Private Wealth LLC cut its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 92.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,627 shares of the biopharmaceutical company's stock after selling 216,868 shares during the quarter. Live Oak Private Wealth LLC's holdings in Pfizer were worth $449,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of PFE. Capital Advisory Group Advisory Services LLC lifted its stake in shares of Pfizer by 2.9% in the 2nd quarter. Capital Advisory Group Advisory Services LLC now owns 13,542 shares of the biopharmaceutical company's stock valued at $328,000 after purchasing an additional 388 shares during the period. Citizens National Bank Trust Department lifted its stake in Pfizer by 0.9% in the second quarter. Citizens National Bank Trust Department now owns 46,103 shares of the biopharmaceutical company's stock valued at $1,118,000 after buying an additional 395 shares during the period. Peak Asset Management LLC boosted its holdings in shares of Pfizer by 1.4% during the 2nd quarter. Peak Asset Management LLC now owns 28,768 shares of the biopharmaceutical company's stock worth $697,000 after buying an additional 402 shares in the last quarter. Able Wealth Management LLC grew its position in shares of Pfizer by 2.0% during the 2nd quarter. Able Wealth Management LLC now owns 21,128 shares of the biopharmaceutical company's stock worth $512,000 after buying an additional 413 shares during the period. Finally, Boltwood Capital Management increased its stake in shares of Pfizer by 0.7% in the 3rd quarter. Boltwood Capital Management now owns 58,274 shares of the biopharmaceutical company's stock valued at $1,485,000 after acquiring an additional 420 shares in the last quarter. Institutional investors and hedge funds own 68.36% of the company's stock.
Pfizer Inc. $PFE Shares Sold by Meyer Handelman Co.
Meyer Handelman Co. lowered its position in Pfizer Inc. (NYSE:PFE – Free Report) by 3.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,237,617 shares of the biopharmaceutical company's stock after selling 42,830 shares during the quarter. Meyer Handelman Co.'s holdings in Pfizer were worth $31,534,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in the business. GKV Capital Management Co. Inc. acquired a new position in Pfizer during the first quarter worth about $27,000. Curio Wealth LLC increased its stake in shares of Pfizer by 36,600.0% during the 2nd quarter. Curio Wealth LLC now owns 1,101 shares of the biopharmaceutical company's stock worth $27,000 after purchasing an additional 1,098 shares in the last quarter. Bayforest Capital Ltd acquired a new position in shares of Pfizer during the 1st quarter worth approximately $28,000. Harbor Asset Planning Inc. acquired a new position in shares of Pfizer during the 2nd quarter worth approximately $29,000. Finally, Howard Hughes Medical Institute purchased a new stake in Pfizer in the 2nd quarter valued at approximately $30,000. 68.36% of the stock is currently owned by hedge funds and other institutional investors.
Afro Rose Curly Funmi Wigs with Bang Short Bouncy Curly Bob Wig With Bangs Machine Made Rose Curl Human Hair Wig For Black Women
Brookstone Capital Management Has $6.86 Million Stock Position in Pfizer Inc. $PFE
Brookstone Capital Management lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 134.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 269,381 shares of the biopharmaceutical company's stock after purchasing an additional 154,286 shares during the period. Brookstone Capital Management's holdings in Pfizer were worth $6,864,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. Brighton Jones LLC grew its holdings in Pfizer by 1,282.4% during the fourth quarter. Brighton Jones LLC now owns 666,318 shares of the biopharmaceutical company's stock worth $17,677,000 after purchasing an additional 618,117 shares during the period. Revolve Wealth Partners LLC raised its stake in Pfizer by 12.5% in the fourth quarter. Revolve Wealth Partners LLC now owns 18,766 shares of the biopharmaceutical company's stock valued at $498,000 after buying an additional 2,087 shares during the period. FORA Capital LLC acquired a new stake in shares of Pfizer in the first quarter valued at approximately $439,000. Landscape Capital Management L.L.C. boosted its stake in shares of Pfizer by 38.7% during the 1st quarter. Landscape Capital Management L.L.C. now owns 41,077 shares of the biopharmaceutical company's stock worth $1,041,000 after acquiring an additional 11,469 shares during the period. Finally, Gerber Kawasaki Wealth & Investment Management increased its holdings in shares of Pfizer by 4.8% during the 1st quarter. Gerber Kawasaki Wealth & Investment Management now owns 21,623 shares of the biopharmaceutical company's stock worth $548,000 after acquiring an additional 987 shares during the last quarter. Institutional investors and hedge funds own 68.36% of the company's stock.
For more detailed information, explore updates concerning Live Oak Private.
0 Comments